Skip to content

A little signal. Less noise.

DISCOVER

Catalog Categories

CATEGORIES

Categories will appear when the source is connected.

More possibility. Less searching.

A considered collection of AI tools, trials, and opportunities.

RADAR / PostgreSQLConnection pending

ExploreCatalog

A little signal. Less noise.

Loading the catalog…

RADARGood tools open new possibilities.Explore thoughtfully. Create freely.

Skip to content

A little signal. Less noise.

DISCOVER

Catalog Categories

CATEGORIES

Categories will appear when the source is connected.

More possibility. Less searching.

A considered collection of AI tools, trials, and opportunities.

RADAR / PostgreSQLStorage available

ExploreOffer details

A little signal. Less noise.

Back to catalog

英

英伟达支持的 AI 制药公司 Iambic 寻求美国上市

Readhub

About this offer

制药公司 Iambic Therapeutics 拟通过首次公开募股融资至多 1.594 亿美元,英伟达为其股东之一。公司计划以每股 15 至 17 美元的价格发行 938 万股,按发行价区间上限及已发行在外股份计算,公司市值约为 8.058 亿美元。

Offer details

Provider: Readhub
Source: readhub-rss
Score: 57.34
Confidence: 54%

Source evidence

What RADAR observed and classified to build this opportunity. It is what the source published, not a verification that the offer is still active.

ReadhubObserved: Oct 8, 2026Source reliability: 60%
英伟达支持的 AI 制药公司 Iambic 寻求美国上市. 制药公司 Iambic Therapeutics 拟通过首次公开募股融资至多 1.594 亿美元,英伟达为其股东之一。公司计划以每股 15 至 17 美元的价格发行 938 万股,按发行价区间上限及已发行在外股份计算,公司市值约为 8.058 亿美元。
Open source

英伟达支持的 AI 制药公司 Iambic 寻求美国上市

Opens an external website. Availability and terms may change.

Real offers. Useful details.

RADARGood tools open new possibilities.Explore thoughtfully. Create freely.

The catalog shows persisted RADAR opportunities. Storage availability does not mean sources are verified or offers are active.